Rifaximin-α Cuts Healthcare Utilisation in Liver Disease ...Middle East

Medscape - News
Rifaximin-α Cuts Healthcare Utilisation in Liver Disease
Rifaximin-alpha use decreases healthcare utilisation in patients with cirrhosis and hepatic encephalopathy, with fewer hospital visits and encephalopathy episodes in 6 months after prescription. Medscape News UK

Read More Details
Finally We wish PressBee provided you with enough information of ( Rifaximin-α Cuts Healthcare Utilisation in Liver Disease )

Also on site :